A Retrospective Hospital Record Based Analysis on Demographic Profile and Associated Complications/Comorbidities in Type 2 Diabetic Patients Attending a Clinic of Punjab, India
DOI:
https://doi.org/10.12970/2310-9971.2017.05.01Keywords:
Type 2 Diabetes Mellitus, Demographic profile, Complications, Comorbidities, Hypertriglyceridemia.Abstract
Background: India is home to the second largest number of adults living with type 2 diabetes (T2D) worldwide. Comorbidities like obesity, hypertension and dyslipidemia have also increased dramatically with rising prevalence of type 2 diabetes and are known to affect both the course and outcome of the disease. The large proportion of patients presenting with T2D in our clinic prompted us to do this study because there is need to increase awareness of metabolic risk factors and how to prevent them. Furthermore, for the prevention and better management of diabetes, it is also vital to know the profile of these patients.References
[1] Diagnosis and Classification Of Diabetes Mellitus. American Diabetes Association. Diabetes Care 2008; 31(1): S55-S60.
[2] Ghatrif M, Kuo YF, Snih S, Raji MA, Ray LA, Markides KS, et al. Trends in Hypertension Prevalence, Awareness, Treatment and Control in Older Mexican Americans, 1993- 2005. Annals of Epidemiology 2011; 21(1): 15-25. http://dx.doi.org/10.1016/j.annepidem.2010.06.002
[3] Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an AHA/NHLBI scientific statement. Circulation 2005; 112: 2735-2752. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404
[4] The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 Diabetes. NEJM 2008; 358: 25602572. http://dx.doi.org/10.1056/NEJMoa0802987
[5] The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 Diabetes. N Engl J Med 2008; 358: 2545-2559. http://dx.doi.org/10.1056/NEJMoa0802743
[6] Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139. http://dx.doi.org/10.1056/NEJMoa0808431
[7] IDF Diabetes Atlas, 7th Edition, 2015.
[8] Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes. Indian scenario. Indian J Med Res 2007; 125: 217-230.
[9] Mohan V, Radhika G, Sathya RM. Dietary carbohydrates, glycaemic load, food groups and newly detected type 2 diabetes among urban Asian Indian population in Chennai, India (Chennai Urban Rural Epidemiology Study 59). Br J Nutr 2009; 102: 1498-1506. http://dx.doi.org/10.1017/S0007114509990468
[10] Mohan V, Shanthi Rani S, Deepa R. Intra urban differences in the prevalence of the metabolic syndrome in southern India: the Chennai Urban Population Study (CUPS-4). Diabetic Med 2001; 18: 280-287. http://dx.doi.org/10.1046/j.1464-5491.2001.00421.x
[11] Kooner JS, Saleheen D, Sim X. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 2011; 43: 984- 989. http://dx.doi.org/10.1038/ng.921
[12] Misra A, Pandey RM, Devi JR. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 2001; 25: 1722-1729. http://dx.doi.org/10.1038/sj.ijo.0801748
[13] Burrows NR, Geiss LS, Engelgau MM, Acton KJ. Prevalence of diabetes among Native Americans and Alaska Natives, 1990–1997: an increasing burden. Diabetes Care 2000; 23: 1786-1790. http://dx.doi.org/10.2337/diacare.23.12.1786
[14] Deepa M, Anjana RM, Manjula D. Convergence of prevalence rates of diabetes and cardio metabolic risk factors in middle and low income groups in urban India: 10- year follow up of the Chennai Urban Population Study. J Diab Sci Technol 2011; 5: 918-927. http://dx.doi.org/10.1177/193229681100500415
[15] Neel JV, Weder AB, Julius S. Type II diabetes, essential hypertension, and obesity as ‘‘syndromes of impaired genetic homeostatis’’ the ‘‘thrifty genotype’’ hypothesis enter the 21st century. Perspect Biol Med 1998; 42: 44-74. http://dx.doi.org/10.1353/pbm.1998.0060
[16] Ahuja MMS. Epidemiological studies on diabetes mellitus in India. In: Ahuja MMS (ed). Epidemiology of diabetes in developing countries. New Delhi:Interprint; 1979; pp. 29-38.
[17] Anjana RM, Pradeepa R, Deepa M. On behalf of the ICMRINDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research–INdiaDIABetes (ICMR–INDIAB) study. Diabetologia 2011; 54: 3022-3027. http://dx.doi.org/10.1007/s00125-011-2291-5
[18] Selby JV, Peng T, Karter AJ, Alexander M, Sidney S, Lian J, et al. High Rates of Co-occurrence of Hypertension, Elevated Low-Density Lipoprotein Cholesterol, and Diabetes Mellitus in a Large Managed Care Population. The American Journal Of Managed Care 2004; 10(2): 163-170.
[19] Rana HM, Chavda P, Rathod CC, Mavani M. SocioDemographic And Anthropometric Profile Of Diabetic Patients Attending Diabetes Clinic In Tertiary Care Hospital Of Central Gujarat. National Journal of Community Medicine Dec 2015; 6(4): 554-557.
[20] Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: Results from the Diab Care India 2011 Study. Mohan V, Shah SN, Joshi SR, Seshiah V, Sahay BK, Banerjee S, Wangnoo SK, et al. Indian Journal of Endocrinology and Metabolism 2014; 18(3): 370-378.
